Literature DB >> 23397258

Association study of CRP gene in systemic sclerosis in European Caucasian population.

Julien Wipff1, Philippe Dieudé, Jérôme Avouac, Eric Hachulla, Jean-Luc Cracowski, Elisabeth Diot, Luc Mouthon, Jean Sibilia, Kiet Tiev, Olivier Meyer, André Kahan, Catherine Boileau, Yannick Allanore.   

Abstract

Opsonization and apoptotic cell elements are critical in systemic lupus erythematosus (SLE) and could act through the activation of the innate immunity. C-reactive protein (CRP) belongs to opsonins, and polymorphisms of CRP gene have been shown to be associated with SLE susceptibility. Accumulating evidences show that SLE and systemic sclerosis (SSc) share some genetic susceptibility factors. To determine whether polymorphisms of CRP confer susceptibility to SSc, four SNPs (rs1130864, rs1205, rs1800947 and rs1341665), chosen using Hapmap linkage disequilibrium data and published data, were genotyped in a cohort of 651 SSc patients (569 with antinuclear antibodies, 258 with anti-centromere and 153 with anti-topoisomerase I) and 442 controls. All individuals were of French Caucasian origin. The four polymorphisms were in Hardy-Weinberg equilibrium in the control population. Allelic and genotypic frequencies for these four polymorphisms were found to be similar in SSc patients and controls. Moreover, subphenotype analyses in particular for subgroups having antinuclear antibodies did not detect any difference between SSc patients and controls. These results obtained through a large cohort of European Caucasian SSc patients do not support the implication of CRP gene in the pathogenesis of SSc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23397258     DOI: 10.1007/s00296-013-2673-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  15 in total

1.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

Authors:  E C LeRoy; C Black; R Fleischmajer; S Jablonska; T Krieg; T A Medsger; N Rowell; F Wollheim
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

Review 2.  Genetic background of systemic sclerosis: autoimmune genes take centre stage.

Authors:  Yannick Allanore; Philippe Dieude; Catherine Boileau
Journal:  Rheumatology (Oxford)       Date:  2009-11-18       Impact factor: 7.580

Review 3.  Anti-CRP antibodies in systemic lupus erythematosus.

Authors:  Olivier Meyer
Journal:  Joint Bone Spine       Date:  2010-06-02       Impact factor: 4.929

Review 4.  Pathways: Strategies for susceptibility genes in SLE.

Authors:  James M Kelley; Jeffrey C Edberg; Robert P Kimberly
Journal:  Autoimmun Rev       Date:  2010-02-08       Impact factor: 9.754

5.  Increased serum pentraxin 3 in patients with systemic sclerosis.

Authors:  Yohei Iwata; Ayumi Yoshizaki; Fumihide Ogawa; Kazuhiro Komura; Toshihide Hara; Eiji Muroi; Motoi Takenaka; Kazuhiro Shimizu; Minoru Hasegawa; Manabu Fujimoto; Kazuhiko Takehara; Shinichi Sato
Journal:  J Rheumatol       Date:  2009-02-27       Impact factor: 4.666

6.  Disease-specific quality indicators, guidelines and outcome measures in scleroderma.

Authors:  G Valentini; M Matucci Cerinic
Journal:  Clin Exp Rheumatol       Date:  2007 Nov-Dec       Impact factor: 4.473

7.  STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis.

Authors:  P Dieudé; M Guedj; J Wipff; B Ruiz; E Hachulla; E Diot; B Granel; J Sibilia; K Tiev; L Mouthon; J L Cracowski; P H Carpentier; Z Amoura; I Fajardy; J Avouac; O Meyer; A Kahan; C Boileau; Y Allanore
Journal:  Arthritis Rheum       Date:  2009-08

Review 8.  C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk.

Authors:  Fadi G Hage; Alexander J Szalai
Journal:  J Am Coll Cardiol       Date:  2007-09-04       Impact factor: 24.094

Review 9.  [Systemic lupus erythematosus: news and therapeutic perspectives].

Authors:  Jean Sibilia; Jean-Louis Pasquali
Journal:  Presse Med       Date:  2008-01-31       Impact factor: 1.228

Review 10.  The clinical relevance of autoantibodies in scleroderma.

Authors:  Khanh T Ho; John D Reveille
Journal:  Arthritis Res Ther       Date:  2003-02-12       Impact factor: 5.156

View more
  2 in total

1.  Correlation of CRP genotypes with serum CRP levels and the risk of rheumatoid arthritis in Chinese Han population.

Authors:  Shanshan Liu; Ju Li; Yongsheng Li; Yan Liu; Kai Wang; Wenyou Pan
Journal:  Clin Rheumatol       Date:  2022-07-28       Impact factor: 3.650

Review 2.  TLR9 polymorphisms and systemic lupus erythematosus risk: an update meta-analysis study.

Authors:  Duan Wang; Chao Zhang; Zongke Zhou; Fuxing Pei
Journal:  Rheumatol Int       Date:  2015-12-07       Impact factor: 2.631

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.